MNK News 84.33 10/16/2014 05:25:46 Mallinckrodt Plc Ordinary

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mallinckrodt Plc Ordinary Share (MNK) 84.33 $MNK

Supernus' Trokendi XR Faces Generic Threat from Zydus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 5:45PM CDT
Supernus Pharmaceuticals, Inc. (SUPN) received a Paragraph IV notice from Zydus which is looking to get its generic version of Supernus' Trokendi XR approved in the U.S.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), SUPN: 8.16 (+0.38), MYL: 47.38 (+0.56)

Mallinckrodt Gives FY15 Guidance Post Questcor Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 4:10PM CDT
Mallinckrodt plc (MNK) has issued its financial guidance for the fiscal year ending Sep 25, 2015 following the completion of the Questcor acquisition.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), LGND: 46.28 (+0.45), MYL: 47.38 (+0.56)

Mallinckrodt expects fiscal 2015 adjusted EPS in the USD6.70 to USD7.20 range
M2 - Wed Oct 15, 6:05AM CDT
Biopharmaceutical company Mallinckrodt (NYSE:MNK) said on Tuesday that it expects its adjusted diluted earnings per share (EPS) in the USD6.70 to USD7.20 range for fiscal year ending 25 September 2015.
MNK: 84.33 (-1.66)

Mallinckrodt shares rise on earnings outlook
AP - Tue Oct 14, 9:07AM CDT
NEW YORK (AP) — Shares of Mallinckrodt PLC rose Tuesday after the health care products maker posted an earnings outlook for next year that beat Wall Street expectations.
MNK: 84.33 (-1.66), QCOR: 93.60 (+1.52)

Mallinckrodt plc Provides Fiscal Year 2015 Financial Guidance
Business Wire - Tue Oct 14, 6:00AM CDT
Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced financial guidance for its fiscal year ending September 25, 2015.
MNK: 84.33 (-1.66)

Trade-Ideas: Mallinckrodt (MNK) Is Today's "Water-Logged And Getting Wetter" Stock
at The Street - Mon Oct 13, 9:59AM CDT
Trade-Ideas LLC identified Mallinckrodt (MNK) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
MNK: 84.33 (-1.66)

10 Stocks Billionaire John Paulson Loves in 2014
at The Street - Mon Oct 13, 9:04AM CDT
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.
MNK: 84.33 (-1.66), AGN: 177.59 (-4.40), QCOR: 93.60 (+1.52), HSH: 62.96 (unch), SHPG: 170.49 (-74.08), COV: 85.86 (-6.50), DTV: 83.63 (-1.23), DG: 58.68 (+0.17), FDO: 76.53 (-0.44), CIE: 10.13 (+0.35)

AxoGen (AXGN) Shows Strength: Stock Up 15.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 8:39AM CDT
AxoGen, Inc. (AXGN) was a big mover last session, as its shares rose over 15% on the day.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), AXGN: 2.91 (+0.02), MYL: 47.38 (+0.56)

'Mad Money' Lightning Round: Buy Kimberly-Clark or Procter & Gamble
at The Street - Sat Oct 11, 5:00AM CDT
Cramer says FMC and Expedia are not done going lower and thinks of Organovo Holdings as a speculative stock.
MNK: 84.33 (-1.66), ONVO: 6.17 (+0.33), KMB: 105.41 (-1.00), EXPE: 74.10 (-0.65), FMC: 54.31 (+1.49), PG: 82.95 (-0.60)

Jim Cramer's Top Stock Picks: ISIS KMB PG MNK
at The Street - Sat Oct 11, 5:00AM CDT
Cramer sees better times ahead for Isis Pharmaceuticals and is a big fan of Kimberly-Clark.
MNK: 84.33 (-1.66), ISIS: 38.97 (+2.13), KMB: 105.41 (-1.00), PG: 82.95 (-0.60)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Oct 10, 6:59PM CDT
From JPMorgan to General Electric, Cramer says he'll be all over earnings next week.
MNK: 84.33 (-1.66), GE: 24.28 (+0.18), HON: 85.11 (-1.08), C: 49.68 (-1.79), KMB: 105.41 (-1.00), MCHP: 37.73 (-0.48), FMC: 54.31 (+1.49), WFC: 47.85 (-0.98), CSX: 32.98 (+0.37), INTC: 31.27 (-0.87), NFLX: 448.59 (-0.53), ISIS: 38.97 (+2.13), JPM: 55.53 (-2.46), ONVO: 6.17 (+0.33), EXPE: 74.10 (-0.65), PG: 82.95 (-0.60), PPG: 180.50 (+2.92)

Impax Up, Set to Buy Tower Holdings & Lineage Therapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 4:05PM CDT
Impax Laboratories Inc.'s (IPXL) signed a definitive agreement to acquire privately held Tower Holding and Lineage Therapeutics.
MNK: 84.33 (-1.66), IPXL: 26.74 (-0.98), ACT: 217.24 (-4.83), MYL: 47.38 (+0.56)

Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:32AM CDT
Impax Laboratories Inc. (IPXL) was a big mover last session, as the company saw its shares rise nearly 12% on the day.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), MYL: 47.38 (+0.56)

Teva Starts Rolling Submission of its Pain Drug CEP-33237 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:45PM CDT
Teva Pharmaceutical (TEVA) started a rolling submission of the NDA in the U.S. for CEP-33237.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), MYL: 47.38 (+0.56), TEVA: 50.09 (+0.19)

Ligand Provides Better-than-Expected Q3 Earnings Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:10PM CDT
Ligand Pharmaceuticals Incorporated (LGND) is expecting its third quarter 2014 adjusted earnings per share to be between 33 and 37 cents per share.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), LGND: 46.28 (+0.45), MYL: 47.38 (+0.56)

Teva to Concentrate on Core Specialty Therapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 5:09PM CDT
Teva Pharmaceutical (TEVA) announced that it will be primarily focusing on its core therapeutic areas.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), TEVA: 50.09 (+0.19), GSK: 43.13 (-0.55)

Actavis in Acquisition Mode, Durata Deal to Boost Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:42PM CDT
Actavis (ACT) will expand its infectious disease portfolio through the Durata (DRTX) acquisition.
DRTX: 23.63 (-0.11), MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), SUPN: 8.16 (+0.38)

Eli Lilly Stops Developing Tabalumab Due to Efficacy Issues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:30PM CDT
Eli Lilly and Company (LLY) will discontinue tabalumab's development due to insufficient efficacy results in the phase III ILLUMINATE program.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), LGND: 46.28 (+0.45), LLY: 62.87 (-0.27)

AbbVie's Humira Label Expanded in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:05PM CDT
AbbVie Inc.'s (ABBV) Humira gained FDA approval for moderately-to-severely active polyarticular juvenile idiopathic arthritis in patients aged less than or equal to 2 years.
MNK: 84.33 (-1.66), ACT: 217.24 (-4.83), LGND: 46.28 (+0.45), ABBV: 54.63 (+0.50)

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 4:05PM CDT
Progenics Pharmaceuticals, Inc. (PGNX) received a $40 million milestone payment from Salix Pharmaceuticals, Inc. (SLXP) on the U.S. approval of Relistor.
MNK: 84.33 (-1.66), PGNX: 4.64 (unch), ACT: 217.24 (-4.83), SLXP: 132.42 (-1.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 128

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
LNG’s Coming Glut Could Gut Global Trading Profits

Updated Category News Views 55

A five-year LNG surplus is the sort of forecast that makes people nod politely today and panic much too late. Bain & Company is putting a hard edge on that risk: the global trading profit pool could slide from an estimated $20 billion in 2026 to roughly $5.5 billion a year during a 2030–34 glut, then potentially tip below zero once cancellation costs bite. That is not a...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 7

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
Full Truck Alliance Profits Surge as Revenue Slows

Updated Category News Views 38

A freight platform just delivered the kind of earnings math that makes investors sit up: sales barely jogged, while profit took off running. Full Truck Alliance’s third-quarter report is plainly strong on the surface, with net income up 49.0% year over year to RMB1.37 billion. Still, this is not a clean, uncomplicated growth story. The quality of the margin jump...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 172

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 112

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 42

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
ROBOTERA Puts Humanoid Robots Into Logistics Night Work

Updated Category News Views 36

Midnight warehouse work is where a humanoid robot has to quit posing and earn its keep. ROBOTERA arrived at the 2026 APEC CEO Summit with a useful answer to the usual shiny-robot nonsense: it says its machines are already working in logistics centers, handling parcel induction and taking on repetitive, physically demanding shifts that people understandably do not line up...

Continue Reading

Top 5 Most Recently Viewed Articles

WM Technology Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 69

Understanding WM Technology's Legal Challenges WM Technology, Inc. has recently found itself at the center of a class action lawsuit, raising significant concerns among its investors. This legal action has been initiated by a prominent law firm advocating for shareholder rights, highlighting serious allegations against the company. Investors are encouraged to stay...

Continue Reading
Nimbello's SyteLine Customer Growth Signals Bright Future Ahead

Updated Category News Views 224

Nimbello's Impressive Growth in the SyteLine Market Nimbello, renowned for its innovative Accounts Payable (AP) automation solutions, has achieved a significant milestone by doubling its customer base among SyteLine users throughout the year. This exciting growth showcases Nimbello's capability and positions it as a leader within the SyteLine ecosystem. Understanding...

Continue Reading
FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead

Updated Category News Views 169

FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead In an exciting development for sports enthusiasts, FRE® Nicotine Pouches has joined forces with Professional Bull Riders (PBR) as their official partner for the iconic Unleash The Beast event series. This remarkable multi-year sponsorship marks a significant milestone for FRE, making it their biggest sports...

Continue Reading
ADP Strengthens Workforce Management with WorkForce Software

Updated Category News Views 92

ADP Expands Its Workforce Management Solutions ADP (NASDAQ: ADP), a leading global technology company in human capital management (HCM) solutions, has made a significant move by acquiring WorkForce Software. This strategic acquisition aims to enhance ADP's workforce management offerings and bolster innovation to address the evolving needs of businesses worldwide....

Continue Reading
MiniLuxe Secures Funding through Innovative Private Placement

Updated Category News Views 305

MiniLuxe Announces a Strategic Private Placement MiniLuxe Holding Corp. has recently made headlines by initiating a non-brokered private placement aimed at raising up to $5 million. This move is geared toward furthering the company’s growth trajectory and expanding its footprint in the beauty and self-care industry. Offering Details and Investor Opportunities This...

Continue Reading